EPCAM and neoplasm: In one out of eight animals (12.5%), the injection of EpCAM/GFPCAR T-cell resulted in a complete regression of the tumor and no visible tumor was observed in the in vivo imaging from day 4 until the end of the experiment (Fig. 3g).